📰 Launch Dynamix News
Page 3 - Launch Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Launch Dynamix. Real-time updates on events, politics, business and more.
October 14, 2022
/PRNewswire/ -- In May of 2022, Sanofi/Regenerons Dupixent (dupilumab) was granted approval by the U.S. FDA to treat eosinophilic esophagitis (EoE) in adults...
October 6, 2022
/PRNewswire/ -- Over the course of this year, AbbVie has proven successful in expanding their immunology portfolio to offset potential Humira losses with the...
October 6, 2022
/PRNewswire/ -- Over the course of this year, AbbVie has proven successful in expanding their immunology portfolio to offset potential Humira losses with the...
August 24, 2022
/PRNewswire/ -- Competition in the generalized myasthenia gravis (gMG) market is heating up with the launches of argenxs Vyvgart and Alexions Ultomiris...
August 24, 2022
/PRNewswire/ -- Competition in the generalized myasthenia gravis (gMG) market is heating up with the launches of argenxs Vyvgart and Alexions Ultomiris...
June 24, 2022
/PRNewswire/ -- Vitiligo is a disease that causes loss of skin color in patches when cells that produce melanin die or stop functioning.1 Spherix recently...
June 22, 2022
/PRNewswire/ -- Spherix recently surveyed 200 EU-based dermatologists across France, Germany, Italy, Spain, and the UK and followed up with ten qualitative...
June 22, 2022
/PRNewswire/ -- Spherix recently surveyed 200 EU-based dermatologists across France, Germany, Italy, Spain, and the UK and followed up with ten qualitative...
June 17, 2022
/PRNewswire/ -- With the approvals of GlaxoSmithKlines Benlysta in lupus nephritis (LN) at the end of 2020 and Aurinias Lupkynis at the beginning of 2021,...
June 9, 2022
/PRNewswire/ -- Three months into the launch of argenxs Vyvgart for generalized myasthenia gravis (gMG) in patients who are anti-acetylcholine receptor...